title: CpG oligodeoxynucleotides enhance FcgammaRI-mediated cross presentation by dendritic cells.
abstract: Dendritic cells (DC) can trigger naive CD8(+) T cell responses by their capacity to cross-present exogenous antigens via the major histocompatibility complex class I pathway. The myeloid class I IgG receptor, FcgammaRI (CD64), is expressed on DC, and in vivo targeting of antigens to FcgammaRI induces strong humoral and cellular immune responses. We studied the capacity of human FcgammaRI (hFcgammaRI) to facilitate DC-mediated cross presentation and T cell activation, and assessed the effect of CpG oligodeoxynucleotides on this process. We generated hFcgammaRI expressing immature DC from hFcgammaRI transgenic and immature DC from non-transgenic mice. Antigens were targeted to Fcgamma receptors as ovalbumin immune complexes, or selectively to hFcgammaRI via ovalbumin-CD64 mAb fusion proteins. Co-incubation of immature DC with CpG ODN led to markedly increased MHC class I presentation of FcgammaR-targeted antigens. When OVA was selectively targeted to hFcgammaRI, few differences were observed between Tg and NTg DC. However, upon co-incubation with CpG ODN, hFcgammaRI-triggered cross presentation was enhanced. These results document the capacity of hFcgammaRI on DC to trigger cross presentation via MHC class I upon co-culture with CpG ODN.
authors.affiliation: Immunotherapy Laboratory, Department of Immunology, University Medical Center Utrecht, Lundlaan 6, Room KC02-085.2, 3584 EA, Utrecht, The Netherlands.
authors.forename: Lisette
authors.initials: L
authors.lastname: Bevaart
authors.forename: Heidi H
authors.initials: HH
authors.lastname: Van Ojik
authors.forename: Amanda W
authors.initials: AW
authors.lastname: Sun
authors.forename: Timothy H
authors.initials: TH
authors.lastname: Sulahian
authors.forename: Jeanette H W
authors.initials: JH
authors.lastname: Leusen
authors.forename: George J
authors.initials: GJ
authors.lastname: Weiner
authors.forename: Jan G J
authors.initials: JG
authors.lastname: Van De Winkel
authors.forename: Martine J
authors.initials: MJ
authors.lastname: Van Vugt
mesh_terms: D000818:Animals; D017951:Antigen Presentation / Q000187:drug effects* / Q000276:immunology; D018414:CD8-Positive T-Lymphocytes / Q000276:immunology*; D003713:Dendritic Cells / Q000276:immunology*; D005805:Genes, MHC Class I / Q000276:immunology*; D006801:Humans; D051379:Mice; D008822:Mice, Transgenic; D009838:Oligodeoxyribonucleotides / Q000494:pharmacology*; D010047:Ovalbumin / Q000276:immunology; D017452:Receptors, IgG / Q000235:genetics / Q000276:immunology*
chemical_list: C489017:FCGR1A protein, human; D009838:Oligodeoxyribonucleotides; D017452:Receptors, IgG; D010047:Ovalbumin